Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
In recent years, major companies in the menopause treatment market have been focusing on different strategies to meet the growing needs of women seeking relief from menopause symptoms. These strategies include launching new products, improving existing ones, and expanding their reach.
In November 2019, Procter & Gamble introduced a new brand called Kindra. Kindra offers products specifically designed to help women cope with menopause by relieving symptoms like hot flashes, mood swings, vaginal dryness, and more.
In April 2019, Otsuka Pharmaceutical launched a non-prescription supplement called EQUELLE in the United States. This supplement is non-hormonal and aims to reduce the frequency of hot flashes and muscle aches associated with menopause.
TherapeuticsMD received FDA approval in October 2018 for its first bioidentical hormone therapy called BIJUVA. This therapy combines estradiol and progesterone and is used to treat moderate to severe vasomotor symptoms associated with menopause.
In July 2017, AMAG Pharmaceuticals, Inc. launched a product called Intrarosa (prasterone). This treatment is specifically for women experiencing moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy caused by menopause.
These product launches and brand introductions are expected to increase the availability of menopause treatments. As a result, the menopause treatment market is expected to grow during the forecast period. By launching new products and brands, these companies are providing more options for women to manage their menopause symptoms. This expansion of treatment choices is likely to drive the growth of the menopause treatment market, as more women will be able to find suitable solutions for their specific needs.
Women Health Disease Diagnosis Treatment Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
